This post was originally published on this site The California Institute for Regenerative Medicine (CIRM) has awarded a $4.6 million grant to researchers at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research for an ongoing Phase 1 clinical trial testing a new immunotherapy for advanced sarcoma and other hard-to-treat cancers.…
This post was originally published on this site I remember when my daughter performed at a talent show at her school. I’d just had my fourth round of chemotherapy, and my condition was critical. For me, every chemo session had its own little life cycle, each with a unique set of challenges and logistics. Because…
This post was originally published on this site Cumulative evidence to date supports the implementation of stereotactic body radiotherapy — a highly precise radiation therapy delivered in shorter periods of time — as a standard treatment for people with localized prostate cancer, a study shows. The study, “Stereotactic Body Radiotherapy for Localized Prostate Cancer: A…
This post was originally published on this site An analysis of circulating tumor DNA, or ctDNA, can help guide treatment decisions for patients with difficult-to-treat high-grade serous ovarian cancer, a study shows. The study, “Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer,” was published in journal Precision Oncology. Cancers generally develop due…
This post was originally published on this site A pivotal Phase 3 clinical trial has begun dosing participants to evaluate MorphoSys‘s investigational antibody, MOR202 (TJ202), in combination with Revlimid (lenalidomide) plus dexamethasone, for the treatment of relapsed or refractory multiple myeloma. The study, ongoing in Taiwan, is being conducted by I-Mab Biopharma, which holds exclusive…
This post was originally published on this site Women with early, low-risk hormone receptor-positive breast cancer are significantly less likely to see their disease return if given radiation therapy and hormone therapy following surgery, according to a trial that followed hundreds of women for nearly 10 years. Specifically, the trial found that whole breast irradiation…
This post was originally published on this site A new program called the Dementia Friendly Hospital Initiative is set to be launched in North Carolina to raise awareness among healthcare providers on how patients with Alzheimer’s disease and dementia experience care interventions and how to meet their needs. Led by the University of North Carolina…
This post was originally published on this site I recently discovered this article celebrating Mother’s Day and found it to be an enjoyable read because it rings true for me. Honest Abe earned his nickname All of us tend to be sentimental about our moms. Inspired by wonderful mothers, many of us could write 100…
This post was originally published on this site Dutch researchers have developed a new experimental protocol that allowed them to culture mini ovarian cancers (organoids) in the lab that retained their three-dimensional structure and captured the cellular diversity seen in patients. These organoids, which mimic the cellular environment and treatment responses in patients, may be…
This post was originally published on this site OncLive, a digital resource platform for oncologists, will welcome 15 new members at its 7th Annual Giants of Cancer Care Winners Reception on May 30 in Chicago, Illinois. Inductees are being recognized for furthering the field of oncology, including multiple myeloma, through research and clinical practices. “We are looking…
